Čájehuvvojit 1 - 7 oktiibuot 7 bohtosis ohcui Shelby S. Fisher (22676406)', ohcanáigi: 0,01s Aiddostahte ozu
  1. 1
    Association of a COVID-19 diagnosis with adverse events, cohort design, follow-up starting on the day after time 0.

    Association of a COVID-19 diagnosis with adverse events, cohort design, follow-up starting on the day after time 0. Dahkki Shelby S. Fisher (22676406)

    Almmustuhtton 2025
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0.

    Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0. Dahkki Shelby S. Fisher (22676406)

    Almmustuhtton 2025
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Eligibility assessment, covariate assessment, and follow-up windows relative to time 0 for the cohort design.

    Eligibility assessment, covariate assessment, and follow-up windows relative to time 0 for the cohort design. Dahkki Shelby S. Fisher (22676406)

    Almmustuhtton 2025
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Estimated Association of a COVID-19 Diagnosis With Neurologic or Immune-Mediated Outcomes: Analysis Starting Follow-Up on the Day After Time 0.

    Estimated Association of a COVID-19 Diagnosis With Neurologic or Immune-Mediated Outcomes: Analysis Starting Follow-Up on the Day After Time 0. Dahkki Shelby S. Fisher (22676406)

    Almmustuhtton 2025
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Characteristics of included individuals for SCRI and cohort analyses.

    Characteristics of included individuals for SCRI and cohort analyses. Dahkki Shelby S. Fisher (22676406)

    Almmustuhtton 2025
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Analysis set for each outcome and definition.

    Analysis set for each outcome and definition. Dahkki Shelby S. Fisher (22676406)

    Almmustuhtton 2025
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Eligibility Assessment, Covariate Assessment, Risk Windows, and Reference Windows Relative to Time 0 for the Self-Controlled Risk Interval Design.

    Eligibility Assessment, Covariate Assessment, Risk Windows, and Reference Windows Relative to Time 0 for the Self-Controlled Risk Interval Design. Dahkki Shelby S. Fisher (22676406)

    Almmustuhtton 2025
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: